Governor Michelle Lujan Grisham wants prosecutors to determine whether federal drug agents broke state law by deliberately allowing massive fentanyl shipments to flow into New Mexico communities, a move that escalates one of the most damaging scandals to hit the Drug Enforcement Administration in years.
Lujan Grisham formally asked New Mexico Attorney General Raúl Torrez to open a criminal investigation into the DEA's conduct, the Associated Press reported. At the center of her request: allegations that DEA agents knowingly allowed hundreds of thousands of fentanyl pills to reach the streets between 2023 and 2025 as part of a strategy to build cases against higher-ranking drug traffickers.
The pills were not intercepted. They were not seized at the point of delivery. They allegedly made it into the hands of dealers and, from there, into communities already buckling under a drug crisis that has killed thousands of New Mexicans.
The AP investigation laid out a pattern: DEA agents tracked major fentanyl shipments moving through New Mexico but chose not to seize them, opting instead to surveil the drugs in hopes of identifying and prosecuting cartel figures further up the supply chain. The tactic is sometimes called "controlled delivery" or "pass-through" enforcement, a high-risk approach that law enforcement agencies have used in various drug operations for decades.
One internal DEA report documented a 2023 delivery of 74,000 fentanyl pills that agents watched arrive at an Albuquerque mobile home park. Agents surveilled the shipment but did not move to confiscate it, Breitbart reported. The pills, by the agency's own records, were allowed to continue into circulation.
The question now facing state investigators is whether that decision, and others like it over a two-year window, crossed the line from aggressive federal strategy into criminal negligence under New Mexico law.
Lujan Grisham did not hold back in her public statements. The governor framed the DEA's conduct as a knowing sacrifice of New Mexican lives in pursuit of federal case-building goals.
"There are no words to describe how reckless and dangerous these decisions were. Make no mistake: the DEA knew people would die if these pills made it into New Mexico communities, and the agency let it happen anyway."
She followed that with a line that cut to the core of the state-federal tension driving this scandal.
"New Mexican lives are not the federal government's cost of doing business."
The governor's language positions this not as a policy disagreement but as a potential criminal act by federal officers operating on state soil. That framing sets up a collision between state criminal authority and federal law enforcement discretion that could test legal boundaries if Torrez moves forward with the probe.
The timing of the DEA's alleged pass-through operations makes the scandal harder to defend. During the same period the agency was allegedly letting fentanyl shipments walk, New Mexico saw a 21 percent spike in overdose deaths. That increase came even as nationwide overdose fatalities fell 14 percent last year.
New Mexico was moving in the opposite direction from the rest of the country. And the DEA, the agency charged with stopping exactly this kind of carnage, allegedly had eyes on the pills and let them go.
The human cost of that divergence is not abstract. A recent incident in the small town of Mountainair, New Mexico, illustrated the lethal potency of the fentanyl variants now circulating in the state. Three people died and 25 first responders were exposed to a powdered opioid substance at a single home, Fox News reported. Twenty of those first responders were hospitalized and released. Two remained in serious condition.
New Mexico State Police Chief Matt Broom confirmed the substance found at the scene.
"Preliminary findings indicate this incident is tied to exposure to a powdered opioid substance within the home, and on-scene DEA laboratory analysis has confirmed the presence of fentanyl, methamphetamine, and para-fluorofentanyl, also called P4 fentanyl."
Para-fluorofentanyl is a rare and more potent variant of the already deadly synthetic opioid. Its presence in a rural New Mexico home underscores just how deeply these substances have penetrated communities far from major trafficking corridors.
Chief Broom praised the emergency personnel who walked into the Mountainair scene without knowing what they would encounter.
"These men and women responded to a dangerous situation while working to protect lives and secure the scene," Broom said. The fact that two dozen first responders required medical attention from a single exposure event speaks to the sheer lethality of the substances now on New Mexico's streets.
The Mountainair incident has not been directly linked to any specific DEA pass-through operation. But it exists within the same ecosystem of fentanyl saturation that the governor says the DEA's strategy made worse. When an agency allows hundreds of thousands of pills to reach the street, the downstream consequences are not hypothetical. They show up in body counts, in hospitalized paramedics, and in small-town homes turned into hazmat scenes.
The DEA scandal fits a broader pattern of federal and state officials facing allegations that their decisions, or their failures to act, caused direct harm to the public. The dynamic is not unique to New Mexico. Federal prosecutors recently arrested the former chief of staff to New York City Mayor Eric Adams in a sweeping corruption crackdown that exposed layers of alleged government misconduct.
In a separate case, the EPA filed criminal referrals alleging Democratic officials steered contracts to themselves, another example of public servants allegedly abusing the trust placed in them.
What makes the New Mexico DEA situation distinct is the body count. Corruption cases involve money and power. This one involves a federal agency allegedly making a calculated decision that it knew would result in civilian deaths, and proceeding anyway.
Lujan Grisham's referral to the attorney general raises thorny jurisdictional questions. DEA agents operate under federal authority. Whether a state prosecutor can bring criminal charges against federal officers for actions taken in the course of their official duties is a legal question that could end up in federal court on immunity grounds long before any grand jury hears evidence.
Federal officers generally enjoy broad protections under the Supremacy Clause of the Constitution, which can shield them from state prosecution for conduct within the scope of their federal duties. But those protections are not absolute. If state investigators can show that DEA agents' actions fell outside the bounds of lawful federal authority, or violated specific state criminal statutes in ways that federal law does not authorize, the immunity shield could crack.
The political pressure on Attorney General Torrez to act is substantial. Whistleblowers within the DEA have reportedly come forward. Congressional members have weighed in. Families of overdose victims are demanding answers. The question is whether Torrez will conclude that the facts support a criminal case, or whether the jurisdictional barriers prove too high.
The situation echoes other recent federal referrals targeting state-level officials for alleged failures in their duties, though here the dynamic is reversed: a state government is pointing the finger at federal agents.
Several critical questions remain unanswered. Authorities have not publicly confirmed how many total fentanyl pills the DEA allowed to pass through New Mexico during the two-year period. The 74,000-pill Albuquerque delivery is one documented instance, but the governor's language, referring to "hundreds of thousands" of pills, suggests the scope is far larger.
Investigators will need to determine whether DEA leadership in Washington approved the pass-through strategy or whether it was driven by field-level decisions in the Albuquerque division. They will also need to assess whether any of the allowed shipments can be traced to specific overdose deaths, a connection that could transform a policy failure into a criminal liability.
No public results have been released about whether the DEA's strategy actually produced the high-level trafficking prosecutions it was designed to generate. If the agency let pills walk and still failed to land major cases, the cost-benefit calculus collapses entirely.
The federal bribery indictment of a former New York City chief of staff showed that even powerful political figures can face accountability when the evidence supports charges. Whether the same principle applies to federal drug agents who allegedly let poison flow into American communities is the question New Mexico is now forcing into the open.
The DEA has not, as of the AP's reporting, offered a detailed public defense of its New Mexico operations. The agency's silence leaves a vacuum that the governor, whistleblowers, and grieving families have filled with damning allegations. If the agency has a justification for allowing fentanyl to reach the streets in quantities sufficient to kill hundreds, the public has not heard it.
New Mexico's overdose crisis did not happen in a vacuum. Cartels manufactured the pills. Traffickers moved them. Dealers sold them. But if federal agents watched it happen, tracked the shipments, and chose to let them land, the chain of responsibility extends into the halls of the agency tasked with stopping exactly this.
When the agency designed to protect Americans from deadly drugs allegedly becomes the reason those drugs reach the street, the question stops being about policy and starts being about criminal law. New Mexico's governor has made her position clear. Now the state's top prosecutor has to decide whether the evidence backs it up.
